Agilent Technologies Inc - ESG Rating & Company Profile powered by AI
If you are employed by Agilent Technologies Inc and you wish to licence your Sustainability rating, please get in touch. The page is a zero-cost Environmental, Social and Governance report covering Agilent Technologies Inc. Check the bottom of this webpage for potential risks for Agilent Technologies Inc based on sector, location and marketcap.
Agilent Technologies Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Agilent Technologies Inc | 8.0 | High |
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Agilent Technologies Inc have an accelerator or VC vehicle to help deliver innovation?
Does Agilent Technologies Inc disclose current and historical energy intensity?
Does Agilent Technologies Inc report the average age of the workforce?
Does Agilent Technologies Inc reference operational or capital allocation in relation to climate change?
Does Agilent Technologies Inc disclose its ethnicity pay gap?
Does Agilent Technologies Inc disclose cybersecurity risks?
Does Agilent Technologies Inc offer flexible work?
Does Agilent Technologies Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Agilent Technologies Inc disclose the number of employees in R&D functions?
Does Agilent Technologies Inc conduct supply chain audits?
Does Agilent Technologies Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Agilent Technologies Inc conduct 360 degree staff reviews?
Does Agilent Technologies Inc disclose the individual responsible for D&I?
Does Agilent Technologies Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Agilent Technologies Inc disclose current and / or historical scope 2 emissions?
Does Agilent Technologies Inc disclose water use targets?
Does Agilent Technologies Inc have careers partnerships with academic institutions?
Did Agilent Technologies Inc have a product recall in the last two years?
Does Agilent Technologies Inc disclose incidents of discrimination?
Does Agilent Technologies Inc allow for Work Councils/Collective Agreements to be formed?
Has Agilent Technologies Inc issued a profit warning in the past 24 months?
Does Agilent Technologies Inc disclose parental leave metrics?
Does Agilent Technologies Inc disclose climate scenario or pathway analysis?
Does Agilent Technologies Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Agilent Technologies Inc disclose the pay ratio of women to men?
Does Agilent Technologies Inc support suppliers with sustainability related research and development?
Does Agilent Technologies Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Agilent Technologies Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Agilent Technologies Inc involved in embryonic stem cell research?
Does Agilent Technologies Inc disclose GHG and Air Emissions intensity?
Does Agilent Technologies Inc disclose its waste policy?
Does Agilent Technologies Inc report according to TCFD requirements?
Does Agilent Technologies Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Agilent Technologies Inc disclose energy use targets?
Does Agilent Technologies Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Agilent Technologies Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Agilent Technologies Inc
These potential risks are based on the size, segment and geographies of the company.
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquar